GlaxoSmithKline plc (GSK.L)
-LSE 1,712.50 
5.00(0.29%) May 17, 11:35AM EDT
| Prev Close: | 1,707.50 |
|---|
| Open: | 1,700.50 |
|---|
| Bid: | 1,712.00 |
|---|
| Ask: | 1,713.00 |
|---|
| 1y Target Est: | 1,641.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1,695.50 - 1,718.00 |
|---|
| 52wk Range: | 1,314.00 - 1,737.26 |
|---|
| Volume: | 7,252,167 |
|---|
| Avg Vol (3m): | 7,336,990 |
|---|
| Market Cap: | 82.95B |
|---|
| P/E (ttm): | 2,012.34 |
|---|
| EPS (ttm): | 0.85 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Headlines
- 3 Most Important Upcoming FDA Decisions of 2013at Motley Fool(Fri, May 17)
- Puma Biotech Gains After Rival Drug Data Show No Threatat Bloomberg(Fri, May 17)
- Glaxo Sees Emerging Market Price Cuts Driving Drug Volume Growthat Bloomberg(Fri, May 17)
- The Beginners' Portfolio Is Up 32% in Its First Year!at Motley Fool(Thu, May 16)
- Chief executives and the itch to quitReuters(Thu, May 16)
- Bristol melanoma drug combo marks new advance in immunotherapyat Reuters(Wed, May 15)
- U.S. STOCKS-Wall St ends near flat after recent highs; healthcare climbsat Reuters(Mon, May 13)
- US STOCKS-Wall St ends near flat after recent gains; healthcare climbsat Reuters(Mon, May 13)
- Elan to Pay $1 Billion for Stake in Theravance Royaltiesat Bloomberg(Mon, May 13)
- US STOCKS SNAPSHOT-Wall St pauses for a breather after rallyat Reuters(Mon, May 13)
- US STOCKS-Wall St near flat after recent gains; retail data helpsat Reuters(Mon, May 13)
- US STOCKS-Wall St flat after retail sales, Nasdaq edges higherat Reuters(Mon, May 13)
- GSK, Shell lead U.K. stocks to 8th day of gainsat MarketWatch(Mon, May 13)
- Elan-Theravance deal a big boost for Baupost, Fidelityat Reuters(Mon, May 13)
- 3 FTSE 100 Shares Hitting New Highs: GlaxoSmithKline, BT Group, British American Tobaccoat Motley Fool(Mon, May 13)
Key Statistics
| Forward P/E (1 yr): | 0.13 |
|---|
| P/S (ttm): | 314.95 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 115.50 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 27.89 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | 1.85 |
|---|
Business Summary
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide.
View More